Recruiting A Clinical Study of Personalized Self-DC Vaccine Targeting Neoantigen in Treatment of Advanced Solid Tumor NCT06682117 Conditions Neoantigen, Solid Tumor Cancer, Treatment, +1 more Locations Fudan University Shanghai Cancer Center — Shanghai, Shanghai Municipality, China View Trial Details
Enrolling by Invitation Treatment of Relapsed or Refractory t(8; 21) AML With Targeted AML1-ETO Neoantigen Cytotoxic T Cells (CTL) NCT06499025 Conditions AML, Neoantigen, t(8;21) Locations Shenzhen University General Hospital — Shenzhen, Guangdong, China View Trial Details
